Secondary cutaneous effects of antineoplastic drugs (II): Kinase inhibitors and monoclonal antibodies

Lorena Leal Canosa, María José Fuente González, Miquel Ribera Pibernat

Producció científica: Contribució a revista › Article de revisió › Recerca › Avaluat per experts

Accés al document

@article{749d9634110e4b3d87a324ef5654a4c7,

title = "Secondary cutaneous effects of antineoplastic drugs (II): Kinase inhibitors and monoclonal antibodies",

author = "Canosa, \{Lorena Leal\} and Gonz{\'a}lez, \{Mar{\'i}a Jos{\'e} Fuente\} and Pibernat, \{Miquel Ribera\}",

year = "2009",

month = oct,

day = "1",

doi = "10.1016/S0213-9251(09)72501-8",

language = "English",

volume = "24",

pages = "427--439",

journal = "Piel",

issn = "0213-9251",

publisher = "Ediciones Doyma, S.L.",

number = "8",

}

TY - JOUR

T1 - Secondary cutaneous effects of antineoplastic drugs (II): Kinase inhibitors and monoclonal antibodies

AU - Canosa, Lorena Leal

AU - González, María José Fuente

AU - Pibernat, Miquel Ribera

PY - 2009/10/1

Y1 - 2009/10/1

UR - https://www.scopus.com/pages/publications/70849112902

U2 - 10.1016/S0213-9251(09)72501-8

DO - 10.1016/S0213-9251(09)72501-8

M3 - Review article

SN - 0213-9251

VL - 24

SP - 427

EP - 439

JO - Piel

JF - Piel

IS - 8

ER -